Literature DB >> 26245889

Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective.

Amy Sachs1,2, Leah Blanchard1,2, Amanda Buchanan1, Errol Norwitz1,2,3, Diana W Bianchi1,2,3.   

Abstract

Noninvasive prenatal testing (NIPT) using cell-free DNA is being offered to an increasing number of women. Comprehensive pre-test counseling is complicated by emerging information about the benefits and limitations of testing, as well as the potential to detect incidental findings. Genetic counselors are trained to facilitate informed decision-making; however, not all centers have access to these professionals. To aid in the informed consent process, we have summarized key points to be included in discussions with patients who are considering NIPT.
© 2015 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26245889     DOI: 10.1002/pd.4666

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  18 in total

1.  Genetic Counselors' Perspectives About Cell-Free DNA: Experiences, Challenges, and Expectations for Obstetricians.

Authors:  Patricia K Agatisa; Mary Beth Mercer; Marissa Coleridge; Ruth M Farrell
Journal:  J Genet Couns       Date:  2018-06-27       Impact factor: 2.537

Review 2.  Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era.

Authors:  Stefania Zampatti; Luca Colantoni; Claudia Strafella; Rosaria Maria Galota; Valerio Caputo; Giulia Campoli; Giulia Pagliaroli; Stefania Carboni; Julia Mela; Cristina Peconi; Stefano Gambardella; Raffaella Cascella; Emiliano Giardina
Journal:  Neurogenetics       Date:  2019-03-25       Impact factor: 2.660

3.  Benefits, challenges and ethical principles associated with implementing noninvasive prenatal testing: a Delphi study.

Authors:  Charles Dupras; Stanislav Birko; Aliya Affdal; Hazar Haidar; Marie-Eve Lemoine; Vardit Ravitsky
Journal:  CMAJ Open       Date:  2018-10-31

Review 4.  Screening for fetal chromosomal and subchromosomal disorders.

Authors:  Sarah Harris; Dallas Reed; Neeta L Vora
Journal:  Semin Fetal Neonatal Med       Date:  2017-11-08       Impact factor: 3.926

5.  Implementing Group Prenatal Counseling for Expanded Noninvasive Screening Options.

Authors:  Betsy L Gammon; Laura Otto; Myra Wick; Kristy Borowski; Megan Allyse
Journal:  J Genet Couns       Date:  2017-12-15       Impact factor: 2.537

6.  Nationwide implementation of the non-invasive prenatal test: Evaluation of a blended learning program for counselors.

Authors:  Linda Martin; Janneke T Gitsels-van der Wal; Caroline J Bax; Mijntje J Pieters; Jacqueline C I Y Reijerink-Verheij; Robert-Jan Galjaard; Lidewij Henneman
Journal:  PLoS One       Date:  2022-05-02       Impact factor: 3.752

7.  Talking Points: Women's Information Needs for Informed Decision-Making About Noninvasive Prenatal Testing for Down Syndrome.

Authors:  Aimée C Dane; Madelyn Peterson; Yvette D Miller
Journal:  J Genet Couns       Date:  2018-03-17       Impact factor: 2.537

8.  Offering a choice between NIPT and invasive PND in prenatal genetic counseling: the impact of clinician characteristics on patients' test uptake.

Authors:  Sanne L van der Steen; Diewertje Houtman; Iris M Bakkeren; Robert-Jan H Galjaard; Marike G Polak; Jan J Busschbach; Aad Tibben; Sam R Riedijk
Journal:  Eur J Hum Genet       Date:  2018-10-08       Impact factor: 4.246

9.  Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.

Authors:  Angela Natalie Barrett; Henna Vishal Advani; Lyn S Chitty; Lin Lin Su; Arijit Biswas; Wei Ching Tan; Melissa Hill; Mahesh Choolani
Journal:  Singapore Med J       Date:  2016-06-29       Impact factor: 1.858

10.  Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study.

Authors:  Celine Lewis; Melissa Hill; Lyn S Chitty
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.